Pharmacy Europe - FDA approves Xeomin for the treatment of cervical dystonia and blepharospasm
Links shared publicly online about this topic.
- 973total visits
Pharmacy Europe - FDA approves Xeomin for the treatment of cervical dystonia and blepharospasm
Pharmacy Europe, daily news for pharmacists, hundreds of clinical and best practice articles, online comment and video presentations.
View full resource at pharmacyeurope.net
Tags: Spasmodic Torticollis, Eyelid Disorder, Pharma, FDA, Pharmacist, News, Xeomin
Most Recently Shared on August 4, 2010 at 6:21 am By:
FDA approves Xeomin for the treatment of cervical dystonia and blepharospasm: Merz Pharmaceuticals has announced t... http://bit.ly/aGazsY
Advertisement
